|Articles|May 21, 2010

Medical Economics, Digital Edition, May 21st, 2010

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, May 21st, 2010

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Bipartisan Senate bill would send $10 billion to primary care and rework how Medicare values physician work

Sen. Roger Marshall's obstetrics practice sued more than 700 patients over unpaid bills

The hidden data problem costing physicians time, referrals and patients

Physicians who survive life-threatening illness often clash with their own patient identity

Virtual kidney-care companies show no consistent benefit despite billions in investment, PHTI finds